Dietary inflammatory index and lower glomerular filtration rate in Mexican adults


Por: Rivera-Paredez B., Argoty-Pantoja A.D., Velázquez-Cruz R., Salmerón J., Jiménez-Corona A., González-Villalpando C., Lajous M., Tamayo J., Catzin-Kuhlmann A., Nelson R., Correa-Rotter R., Denova-Gutiérrez E.

Publicada: 1 ene 2024 Ahead of Print: 1 jun 2024
Resumen:
We hypothesized that higher scores on the dietary inflammatory index (DII) would be associated with a lower glomerular filtration rate (GFR). This cross-sectional study included 2098 participants from Mexican Teachers Cohort Study, the Health Workers Cohort Study, and the Comitán Study belonging to the RenMex consortium. Energy-adjusted DII scores were estimated using a semi-quantitative food frequency questionnaire (FFQ). eGFR was estimated by the CKD Epidemiology Collaboration equation. Quantile regression models and ordered regression models were estimated to assess the associations of interest. Median age of study participants was 47 years, median eGFR was 102.9 mL/min/1.73m2, and the median energy-adjusted DII was 0.89 (range, -2.25, +4.86). The median eGFR was lower in participants in the highest percentile of DII compared to those in the lowest percentile (103.8 vs 101.4). We found that continuous and categorical energy-adjusted DII scores were associated with lower eGFR, especially at the lower percentiles. In adjusted ordered logistic regression, we found that the highest DII category was associated with 1.80 times the odds of belonging to the mildly decreased eGFR category or moderately decreased eGFR category compared lowest DII category (OR: 1.80, 95%CI 1.35, 2.40). A high DII score was associated with a lower eGFR among the Mexican population. Additional studies are crucial to validate these findings and explore potential strategies to reduce the consumption of pro-inflammatory foods as a preventive approach for chronic kidney disease (CKD). © 2024 Elsevier Inc.

Filiaciones:
Rivera-Paredez B.:
 Research Center in Policies, Population and Health, School of Medicine, National Autonomous, University of Mexico (UNAM), Mexico City, Mexico

Argoty-Pantoja A.D.:
 Research Center in Policies, Population and Health, School of Medicine, National Autonomous, University of Mexico (UNAM), Mexico City, Mexico

Velázquez-Cruz R.:
 Genomics of Bone Metabolism Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico

Salmerón J.:
 Research Center in Policies, Population and Health, School of Medicine, National Autonomous, University of Mexico (UNAM), Mexico City, Mexico

Jiménez-Corona A.:
 Department of Ocular Epidemiology and Visual Health, Instituto de Oftalmología Conde de, Valenciana, Mexico City, Mexico

González-Villalpando C.:
 Center for Population Health Research, National Institute of Public Health, Cuernavaca, Mexico

Lajous M.:
 Center for Population Health Research, National Institute of Public Health, Cuernavaca, Mexico

Tamayo J.:
 Accesalud, Mexico City, Mexico

Catzin-Kuhlmann A.:
 Dirección de Medicina, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Nelson R.:
 Chronic Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney, Diseases, Phoenix, Arizona, United States

Correa-Rotter R.:
 Departamento de Nefrología y Metabolismo Mineral, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Denova-Gutiérrez E.:
 Nutrition and Health Research Center, National Institute of Public Health, Morelos, Cuernavaca, Mexico
ISSN: 02715317
Editorial
PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND, Estados Unidos America
Tipo de documento: Article
Volumen: 127 Número:
Páginas: 53-62
WOS Id: 001257036400001
ID de PubMed: 38876039